<DOC>
	<DOCNO>NCT02328014</DOCNO>
	<brief_summary>This study evaluate safety , pharmacokinetics ( PK ) , pharmacodynamics ( PD ) , efficacy ACP-196 ACP 319 B-cell malignancy .</brief_summary>
	<brief_title>ACP-196 Combination With ACP-319 , Treatment B-Cell Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>Main Diagnosis bcell malignancy document medical record histology base criterion establish World Health Organization ( WHO ) . Eastern Cooperative Oncology Group ( ECOG ) performance status â‰¤ 2 . Agreement use contraception study 90 day last dose study drug sexually active able bear beget child . Exclusion Criteria A lifethreatening illness , medical condition organ system dysfunction , investigator 's opinion , could compromise subject 's safety , interfere absorption metabolism study drug , put study outcome undue risk . Central nervous system ( CNS ) involvement lymphoma/leukemia Any therapeutic antibody within 4 week first dose study drug . The time last dose recent chemotherapy experimental therapy first dose study drug &lt; 5 time halflife previously administer agent ( ) . ANC &lt; 0.5 x 10^9/L platelet count &lt; 50 x 10^9/L unless due disease involvement bone marrow . Creatinine &gt; 1.5 x institutional upper limit normal ( ULN ) ; total bilirubin &gt; 1.5 x ULN ( unless due Gilbert 's disease ) ; aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &gt; 3.0 x ULN .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Bruton tyrosine kinase inhibitor</keyword>
	<keyword>Btk</keyword>
	<keyword>B-Cell Malignancies</keyword>
	<keyword>Mantle Cell</keyword>
	<keyword>Multiple Myeloma</keyword>
	<keyword>CLL</keyword>
	<keyword>SLL</keyword>
	<keyword>DLBCL</keyword>
	<keyword>Folicular</keyword>
	<keyword>Waldenstrom</keyword>
	<keyword>B-All</keyword>
</DOC>